Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: SIMENDAN - , . Treffer: 5
2021
Heringlake, M; Alvarez, J; Bettex, D; Bouchez, S; Fruhwald, S; Girardis, M; Grossini, E; Guarracino, F; Herpain, A; Toller, W; Tritapepe, L; Pollesello, P
An update on levosimendan in acute cardiac care: applications and recommendations for optimal efficacy and safety.
EXPERT REV CARDIOVAS. 2021; 19(4): 325-335.
Doi: 10.1080/14779072.2021.1905520
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2017
Pölzl, G; Altenberger, J; Baholli, L; Beltrán, P; Borbély, A; Comin-Colet, J; Delgado, JF; Fedele, F; Fontana, A; Fruhwald, F; Giamouzis, G; Giannakoulas, G; Garcia-González, MJ; Gustafsson, F; Kaikkonen, K; Kivikko, M; Kubica, J; von Lewinski, D; Löfman, I; Malfatto, G; Manito, N; Martínez-Sellés, M; Masip, J; Merkely, B; Morandi, F; Mølgaard, H; Oliva, F; Pantev, E; Papp, Z; Perna, GP; Pfister, R; Piazza, V; Bover, R; Rangel-Sousa, D; Recio-Mayoral, A; Reinecke, A; Rieth, A; Sarapohja, T; Schmidt, G; Seidel, M; Störk, S; Vrtovec, B; Wikström, G; Yerly, P; Pollesello, P
Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy.
Int J Cardiol. 2017; 243(3):389-395
Doi: 10.1016/j.ijcard.2017.05.081
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Fruhwald, S; Pollesello, P; Fruhwald, F
Advanced heart failure: an appraisal of the potential of levosimendan in this end-stage scenario and some related ethical considerations.
Expert Rev Cardiovasc Ther. 2016; 14(12):1335-1347
Doi: 10.1080/14779072.2016.1247694
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Mehta, RH; Van Diepen, S; Meza, J; Bokesch, P; Leimberger, JD; Tourt-Uhlig, S; Swartz, M; Parrotta, J; Jankowich, R; Hay, D; Harrison, RW; Fremes, S; Goodman, SG; Luber, J; Toller, W; Heringlake, M; Anstrom, KJ; Levy, JH; Harrington, RA; Alexander, JH; LEVO-CTS Investigators
Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial.
Am Heart J. 2016; 182(12):62-71
Doi: 10.1016/j.ahj.2016.09.001
Web of Science
PubMed
FullText
FullText_MUG
2015
Toller, W; Heringlake, M; Guarracino, F; Algotsson, L; Alvarez, J; Argyriadou, H; Ben-Gal, T; Černý, V; Cholley, B; Eremenko, A; Guerrero-Orriach, JL; Järvelä, K; Karanovic, N; Kivikko, M; Lahtinen, P; Lomivorotov, V; Mehta, RH; Mušič, Š; Pollesello, P; Rex, S; Riha, H; Rudiger, A; Salmenperä, M; Szudi, L; Tritapepe, L; Wyncoll, D; Öwall, A
Preoperative and perioperative use of levosimendan in cardiac surgery: European expert opinion.
Int J Cardiol. 2015; 184(5):323-336
Doi: 10.1016/j.ijcard.2015.02.022
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG